Individuals with HIV and hepatocellular carcinoma (HCC) have a higher risk of both all-cause and cancer-specific mortality compared with those without HIV, highlighting the need for improving prevention, screening, and diagnostic strategies for this aging population.
Researchers sourced data for this analysis from US HIV and cancer registries to examine survival outcomes among patients with HCC. The analysis included 71,516 patients aged 20 to 79 years who developed HCC between 2001 and 2019, a period involving advancements in both HIV and HCC treatments.
/Infectious Disease Advisor requires free registration if more than 5 articles are viewed per month/
Source : Infectious Disease Advisor
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.